Cardiometabolic Risk Effects of Short-term Cessation of Neurostimulation Therapy (NCT06720545)
Cardiometabolic Risk Effects of Short-term Cessation of Effective Neurostimulation Therapy in OSA
🩺 Plain-English Summary (8th-Grade Level)
Hypoglossal nerve stimulation (HGNS) is an implantable therapy that treats obstructive sleep apnea. The study will evaluate the effect of this treatment on cardiovascular and metabolism-related measures to see if it affects patients' risk of medical problems associated with obstructive sleep apnea (OSA).
Who can join: Review the eligibility criteria below.
Location: Columbia University Medical Center — New York, New York
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Columbia University Medical Center — New York, New York
📞 Contact the Study Coordinator
Phone: (646) 317-3252
Email: otosleepresearch@cumc.columbia.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Obstructive Sleep Apnea
- RPMO2 Oximeter Accuracy During Sleep 1 Trial — Dallas, Texas
- Validation of Sleep Questionnaires in the Down Syndrome Population — Portland, Oregon
- 3D Printer Modified CPAP Mask for Obstructive Sleep Apnea — Boston, Massachusetts
- Breathing Training for Improving Cardiovascular Health in Older Adults With Sleep Apnea — Tucson, Arizona
- Obstructive Sleep Apnea in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation — Memphis, Tennessee
- Obstructive Sleep Apnea (OSA) and Sex-Specific Responses to N-acetylcysteine (NAC) — New York, New York
Explore by condition: All Obstructive Sleep Apnea clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.